Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran

<p>Abstract</p> <p>Genetic and phylogenetic information on the HIV-1 epidemic in Middle-East Countries, and in particular in Iran, are extremely limited. By March 2004, the Iranian Ministry of Health officially reported a cumulative number of 6'532 HIV positive individuals and...

Full description

Bibliographic Details
Main Authors: Buonaguro FM, Rezza G, Farid R, Ciccozzi M, Tornesello ML, Tagliamonte M, Naderi HR, Buonaguro L
Format: Article
Language:English
Published: BMC 2006-09-01
Series:Infectious Agents and Cancer
Online Access:http://www.infectagentscancer.com/content/1/1/4
_version_ 1811266684010364928
author Buonaguro FM
Rezza G
Farid R
Ciccozzi M
Tornesello ML
Tagliamonte M
Naderi HR
Buonaguro L
author_facet Buonaguro FM
Rezza G
Farid R
Ciccozzi M
Tornesello ML
Tagliamonte M
Naderi HR
Buonaguro L
author_sort Buonaguro FM
collection DOAJ
description <p>Abstract</p> <p>Genetic and phylogenetic information on the HIV-1 epidemic in Middle-East Countries, and in particular in Iran, are extremely limited. By March 2004, the Iranian Ministry of Health officially reported a cumulative number of 6'532 HIV positive individuals and 214 AIDS cases in the Iranian HIV-1 epidemic. The intra-venous drug users (IDUs) represent the group at highest risk for HIV-1 infection in Iran, accounting for almost 63% of all HIV-infected population. In this regards, a molecular phylogenetic study has been performed on a sentinel cohort of HIV-1 seropositive IDUs enrolled at the end of 2005 at the University of Mashhad, the largest city North East of Tehran. The study has been performed on both <it>gag </it>and <it>env </it>subgenomic regions amplified by Polymerase Chain Reaction (PCR) from peripheral blood mononuclear cells (PBMCs) and characterized by direct DNA sequence analysis. The results reported here show that the HIV-1 subtype A is circulating in this IDUs sentinel cohort. Moreover, the single phylogenetic cluster as well as the <it>intra</it>-group low nucleotide divergence is indicative of a recent outbreak. Unexpectedly, the Iranian samples appear to be phylogenetically derived from African Sub-Saharan subtype A viruses, raising stirring speculations on HIV-1 introduction into the IDUs epidemic in Mashhad. This sentinel study could represent the starting point for a wider molecular survey of the HIV-1 epidemics in Iran to evaluate in detail the distribution of genetic subtypes and possible natural drug-resistant variants, which are extremely helpful information to design diagnostic and therapeutic strategies.</p>
first_indexed 2024-04-12T20:47:42Z
format Article
id doaj.art-02185d2a91df483bafd7e274a2a004d1
institution Directory Open Access Journal
issn 1750-9378
language English
last_indexed 2024-04-12T20:47:42Z
publishDate 2006-09-01
publisher BMC
record_format Article
series Infectious Agents and Cancer
spelling doaj.art-02185d2a91df483bafd7e274a2a004d12022-12-22T03:17:12ZengBMCInfectious Agents and Cancer1750-93782006-09-0111410.1186/1750-9378-1-4Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-IranBuonaguro FMRezza GFarid RCiccozzi MTornesello MLTagliamonte MNaderi HRBuonaguro L<p>Abstract</p> <p>Genetic and phylogenetic information on the HIV-1 epidemic in Middle-East Countries, and in particular in Iran, are extremely limited. By March 2004, the Iranian Ministry of Health officially reported a cumulative number of 6'532 HIV positive individuals and 214 AIDS cases in the Iranian HIV-1 epidemic. The intra-venous drug users (IDUs) represent the group at highest risk for HIV-1 infection in Iran, accounting for almost 63% of all HIV-infected population. In this regards, a molecular phylogenetic study has been performed on a sentinel cohort of HIV-1 seropositive IDUs enrolled at the end of 2005 at the University of Mashhad, the largest city North East of Tehran. The study has been performed on both <it>gag </it>and <it>env </it>subgenomic regions amplified by Polymerase Chain Reaction (PCR) from peripheral blood mononuclear cells (PBMCs) and characterized by direct DNA sequence analysis. The results reported here show that the HIV-1 subtype A is circulating in this IDUs sentinel cohort. Moreover, the single phylogenetic cluster as well as the <it>intra</it>-group low nucleotide divergence is indicative of a recent outbreak. Unexpectedly, the Iranian samples appear to be phylogenetically derived from African Sub-Saharan subtype A viruses, raising stirring speculations on HIV-1 introduction into the IDUs epidemic in Mashhad. This sentinel study could represent the starting point for a wider molecular survey of the HIV-1 epidemics in Iran to evaluate in detail the distribution of genetic subtypes and possible natural drug-resistant variants, which are extremely helpful information to design diagnostic and therapeutic strategies.</p>http://www.infectagentscancer.com/content/1/1/4
spellingShingle Buonaguro FM
Rezza G
Farid R
Ciccozzi M
Tornesello ML
Tagliamonte M
Naderi HR
Buonaguro L
Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran
Infectious Agents and Cancer
title Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran
title_full Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran
title_fullStr Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran
title_full_unstemmed Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran
title_short Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran
title_sort molecular and phylogenetic analysis of hiv 1 variants circulating among injecting drug users in mashhad iran
url http://www.infectagentscancer.com/content/1/1/4
work_keys_str_mv AT buonagurofm molecularandphylogeneticanalysisofhiv1variantscirculatingamonginjectingdrugusersinmashhadiran
AT rezzag molecularandphylogeneticanalysisofhiv1variantscirculatingamonginjectingdrugusersinmashhadiran
AT faridr molecularandphylogeneticanalysisofhiv1variantscirculatingamonginjectingdrugusersinmashhadiran
AT ciccozzim molecularandphylogeneticanalysisofhiv1variantscirculatingamonginjectingdrugusersinmashhadiran
AT torneselloml molecularandphylogeneticanalysisofhiv1variantscirculatingamonginjectingdrugusersinmashhadiran
AT tagliamontem molecularandphylogeneticanalysisofhiv1variantscirculatingamonginjectingdrugusersinmashhadiran
AT naderihr molecularandphylogeneticanalysisofhiv1variantscirculatingamonginjectingdrugusersinmashhadiran
AT buonagurol molecularandphylogeneticanalysisofhiv1variantscirculatingamonginjectingdrugusersinmashhadiran